##gff-version 3
##sequence-region Q9Y5C1 1 460
Q9Y5C1	UniProtKB	Signal peptide	1	16	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15340161;Dbxref=PMID:15340161	
Q9Y5C1	UniProtKB	Chain	17	460	.	.	.	ID=PRO_0000009122;Note=Angiopoietin-related protein 3	
Q9Y5C1	UniProtKB	Chain	17	224	.	.	.	ID=PRO_0000435903;Note=ANGPTL3(17-224);Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:12909640;Dbxref=PMID:12909640	
Q9Y5C1	UniProtKB	Chain	17	221	.	.	.	ID=PRO_0000435904;Note=ANGPTL3(17-221);Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:12909640;Dbxref=PMID:12909640	
Q9Y5C1	UniProtKB	Domain	237	455	.	.	.	Note=Fibrinogen C-terminal;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00739	
Q9Y5C1	UniProtKB	Region	17	207	.	.	.	Note=Sufficient to inhibit LIPG/EL phospholipase activity;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17110602;Dbxref=PMID:17110602	
Q9Y5C1	UniProtKB	Region	17	165	.	.	.	Note=Sufficient to inhibit LPL lipase activity;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12909640;Dbxref=PMID:12909640	
Q9Y5C1	UniProtKB	Region	32	56	.	.	.	Note=Required for inhibition of LPL lipase activity;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19318355;Dbxref=PMID:19318355	
Q9Y5C1	UniProtKB	Coiled coil	85	210	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9Y5C1	UniProtKB	Glycosylation	115	115	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10644446,ECO:0000269|PubMed:16335952;Dbxref=PMID:10644446,PMID:16335952	
Q9Y5C1	UniProtKB	Glycosylation	226	226	.	.	.	Note=O-linked (GalNAc) threonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20837471;Dbxref=PMID:20837471	
Q9Y5C1	UniProtKB	Glycosylation	296	296	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16335952,ECO:0000269|PubMed:19159218;Dbxref=PMID:16335952,PMID:19159218	
Q9Y5C1	UniProtKB	Glycosylation	357	357	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16335952;Dbxref=PMID:16335952	
Q9Y5C1	UniProtKB	Disulfide bond	246	274	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00739	
Q9Y5C1	UniProtKB	Disulfide bond	394	408	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00739	
Q9Y5C1	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_075670;Note=Associated with low plasma triglyceride level%3B fails to suppress LPL activity in vitro. K->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19075393;Dbxref=dbSNP:rs146749211,PMID:19075393	
Q9Y5C1	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_075671;Note=Associated with low plasma triglyceride level%3B fails to suppress LPL activity in vitro. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19075393;Dbxref=dbSNP:rs139334976,PMID:19075393	
Q9Y5C1	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_067283;Note=L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22095935;Dbxref=dbSNP:rs72649573,PMID:22095935	
Q9Y5C1	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_075672;Note=Associated with low plasma triglyceride level%3B fails to suppress LPL activity in vitro. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19075393;Dbxref=dbSNP:rs775976787,PMID:19075393	
Q9Y5C1	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_075673;Note=Associated with low plasma triglyceride level%3B fails to suppress LPL activity in vitro%3B no effect on protein secretion. N->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19075393,ECO:0000269|PubMed:25733326;Dbxref=dbSNP:rs149624466,PMID:19075393,PMID:25733326	
Q9Y5C1	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_075674;Note=Common allele in African americans%3B associated with low plasma triglyceride level%3B fails to suppress LPL activity in vitro. M->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19075393;Dbxref=dbSNP:rs77871363,PMID:19075393	
Q9Y5C1	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_075675;Note=Abolishes protein secretion%3B associated with low plasma triglyceride level. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19075393;Dbxref=dbSNP:rs763904695,PMID:19075393	
Q9Y5C1	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_075676;Note=Abolishes protein secretion%3B associated with low plasma triglyceride level. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19075393;Dbxref=PMID:19075393	
Q9Y5C1	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_075677;Note=Abolishes protein secretion%3B associated with low plasma triglyceride level. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19075393;Dbxref=dbSNP:rs138899888,PMID:19075393	
Q9Y5C1	UniProtKB	Natural variant	344	344	.	.	.	ID=VAR_075678;Note=Abolishes protein secretion%3B associated with low plasma triglyceride level. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25733326;Dbxref=dbSNP:rs1334979946,PMID:25733326	
Q9Y5C1	UniProtKB	Natural variant	375	375	.	.	.	ID=VAR_075679;Note=Abolishes protein secretion%3B associated with low plasma triglyceride level. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19075393,ECO:0000269|PubMed:25733326;Dbxref=dbSNP:rs768802285,PMID:19075393,PMID:25733326	
Q9Y5C1	UniProtKB	Natural variant	417	417	.	.	.	ID=VAR_075680;Note=Abolishes protein secretion%3B associated with low plasma triglyceride level. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19075393;Dbxref=dbSNP:rs376210525,PMID:19075393	
Q9Y5C1	UniProtKB	Natural variant	418	418	.	.	.	ID=VAR_049071;Note=N->Y;Dbxref=dbSNP:rs4145257	
Q9Y5C1	UniProtKB	Mutagenesis	62	63	.	.	.	Note=Abolishes effect on plasma triglyceride level%3B when associated with N-65. HK->IN;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12909640;Dbxref=PMID:12909640	
Q9Y5C1	UniProtKB	Mutagenesis	63	63	.	.	.	Note=Abolishes inhibitory effect on LIPG/EL phospholipase activity%3B when associated with N-65. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17110602;Dbxref=PMID:17110602	
Q9Y5C1	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Abolishes effect on plasma triglyceride level%3B when associated with 62-I-N-63. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12909640;Dbxref=PMID:12909640	
Q9Y5C1	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Abolishes inhibitory effect on LIPG/EL phospholipase activity%3B when associated with N-63. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17110602;Dbxref=PMID:17110602	
Q9Y5C1	UniProtKB	Mutagenesis	204	205	.	.	.	Note=Abolishes proteolytical cleavage and effect on plasma triglyceride levels%2C keeps in vitro inactivation of LPL activity%3B when associated with S-221%3B S-224 and S-235. RR->TT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12909640;Dbxref=PMID:12909640	
Q9Y5C1	UniProtKB	Mutagenesis	221	221	.	.	.	Note=Abolishes proteolytical cleavage and effect on plasma triglyceride levels%2C keeps in vitro inactivation of LPL activity%3B when associated with 204-T-T-205%3B S-224 and S-235. R->ST;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12909640;Dbxref=PMID:12909640	
Q9Y5C1	UniProtKB	Mutagenesis	224	224	.	.	.	Note=Abolishes proteolytical cleavage and effect on plasma triglyceride levels%2C keeps in vitro inactivation of LPL activity%3B when associated with 204-T-T-205%3B S-221 and S-235. R->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12909640;Dbxref=PMID:12909640	
Q9Y5C1	UniProtKB	Mutagenesis	235	235	.	.	.	Note=Abolishes proteolytical cleavage and effect on plasma triglyceride levels%2C keeps in vitro inactivation of LPL activity%3B when associated with 204-T-T-205%3B S-221 and S-224. R->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12909640;Dbxref=PMID:12909640	
Q9Y5C1	UniProtKB	Sequence conflict	134	134	.	.	.	Note=L->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9Y5C1	UniProtKB	Helix	246	251	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	256	262	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	270	277	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	280	291	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Helix	299	304	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	306	308	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	311	314	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Helix	317	324	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	329	337	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	342	351	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Helix	354	356	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	360	369	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	375	377	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	379	383	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Helix	395	397	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	398	400	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	402	404	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	431	435	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	437	439	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
Q9Y5C1	UniProtKB	Beta strand	441	453	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:6EUA	
